跳至主要内容
临床试验/NCT04442555
NCT04442555Unknown1 期

Treatment With the Ketone Body 3-hydroxybutyrate in Patients With Acute Heart Failure

University of Aarhus2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2020年2月1日最近更新:
适应症

试验速览

阶段
1 期
入组人数
12
试验地点
2
主要终点
Cardiac Output (L/min)

研究概览

简要总结

Background:

Acute heart failure is a potentially life-threatening condition, reaching mortality rates of up to 50% in advanced cases. The investigators have shown that infusion of ketone bodies increase cardiac output by 40% in stabile patients with chronic heart failure. However, there are no data showing the effects of ketone on patients with acute heart failure

Objectives:

To investigate the effect of ketone supplementation in patients with acute heart failure and cardiogenic shock, using two different types of oral ketone supplements.

Methods:

The investigators will conduct four randomized placebo-controlled studies, to investigate the hemodynamic effect of exogenous ketones in acute heart failure and cardiogenic shock.

Perspectives:

The present study will determine the potential beneficial effects of ketone supplements in patients with acute heart failure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Hospitalized with worsening HF or de novo diagnosis of HF
  • LVEF < 50%
  • Treatment with intravenous loop diuretics during the hospitalization and/or increased dosage of oral diuretics.

排除标准

  • Cardiogenic shock
  • Systolic Blood Pressure <85 mmHg
  • Acute myocardial infarction other than type II <5 days prior to randomization *
  • Severe uncorrected cardiac valve disease
  • Expected or possible need for hemodialysis as judged by the investigator
  • Ongoing inotropic treatment
  • Possible need for advanced heart failure treatment (LVAD, heart transplantation) as judged by the investigator.
  • Ongoing, severe infection
  • Severe respiratory distress (SAT<90% or RF> 24/min or receiving more than 2 l O2/min or intubated)
  • Atrial Fibrillation with heart >120 beats per minute
  • Inability to cooperate to or accept oral intake of food, including presence of major gastrointestinal discomfort.
  • If suspected or confirmed acute myocardial infarction as cause of acute heart failure, patients can be recruited 5 days after hospitalization in the absence of malignant arrhythmias (e.g. ventricular tachycardia) or clinically significant residual angina pectoris.

结局指标

主要结局

Cardiac Output (L/min)

时间窗: 3 hours - Area under the curve

Right Heart Catherization

Left Ventricular Ejection Fraction

时间窗: 3 hours - Area under the curve

Echocardiography

次要结局

  • Left Ventricular Outflow Tract Velocity Time Integral (cm)(3 hours - Area under the curve)
  • Left Ventricular Filling Pressure (mmHg)(3 hours - Area under the curve)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kristian Hylleberg Christensen

MD, Principal Investigator

University of Aarhus

研究点 (2)

Loading locations...

相似试验